Eva Renee Barnett, Chief Financial Officer at Immunovant, Inc. (IMVT), sold 6,542 shares at $28.79 ($188K) on 2024-10-16, disclosed to the SEC on 2024-10-18.
Seasonal sale ($188k) by Chief Financial Officer — this insider has traded IMVT in October in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.79 | 3,271 | $94K | 50.0% |
| 2 | $28.79 | 3,271 | $94K | 50.0% |
| Total | $28.79 avg | 6,542 | $188K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $117K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $107K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $198K | — | Filing → |